Overview
Following the success of 2022 and 2023, we are proud to announce the next CRU Eye Symposium, set to take place in Napa Valley, California, in March 2025. We extend our heartfelt gratitude to all the attendees of the previous CRU Eye Symposia. Your presence, engagement, and contributions have made these events a resounding success. Thank you for being a part of this remarkable journey, and we look forward to welcoming you again.
CRU, an acronym for "Current, Relevant, and Useful," reflects the nature of the education shared during the event. This symposium is designed for eye care professionals and prioritizes interpersonal interactions, and striking the perfect balance between formal education and interactive experiences. Educational sessions and sponsor interactions will take place in the morning each day. Time is allocated for the Exhibitor Lounge and various leisure activities, with an interactive reception scheduled for Friday evening.
Esteemed speakers, clinicians, and researchers in the eye care field present on topics such as anterior segment disease, glaucoma, retina, advanced contact lenses, myopia management, and more. The CRU Eye Symposium aims to become the most significant annual conference for influential figures in the ophthalmic field. As we move forward, we are eager to continue fostering the spirit of collaboration and knowledge-sharing.
We are excited to see you in March 2025 for another enriching and inspiring event!
Learning Objectives
Upon completion of this activity, participants will be able to:
- Incorporate evidence-based diagnostic strategies for earlier and more accurate identification of both common and rare ocular diseases
- Integrate guidelines and evidence in the development of treatment plans for patients with vision changes and ocular diseases
- Outline the role for novel and recently approved therapies in the management of ocular diseases
- Analyze evidence from clinical trials regarding safety and efficacy of investigational agents
- Develop treatment plans to address common and unusual ocular disease that incorporate patient preferences and shared goals of therapy
Program Co-Chairs
Stephanie L. Woo, OD, FAAO, FSLS; John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS
To view full profile, click on the Program Chair tab above.
